MedPath

Effect of supplementation in treatment of women with cervical intraepithelial neoplasia 2 and 3

Phase 2
Conditions
Cervical intraepithelial neoplasia 2 and 3.
Cervix uteri, unspecified
Registration Number
IRCT2017021417639N2
Lead Sponsor
Vice chancellor for research, Isfahan University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Other
Sex
Female
Target Recruitment
60
Inclusion Criteria

women with cervical intraepithelial neoplasia 2 and 3; aged 18 to 55 years old. Exclusion criterion: unwillingness to cooperate.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Recurrence. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Colposcopy.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath